Skip to main content
OpenTrials

Clinical trial condition

Esophageal Adenocarcinoma

Explore clinical trials studying Esophageal Adenocarcinoma. Study availability and eligibility vary by location and protocol.

93 public trials 45 recruiting studies
Refine in advanced search Browse all conditions

Esophageal Adenocarcinoma trial results

Completed

Tucatinib, Trastuzumab, Ramucirumab, and Paclitaxel Versus Paclitaxel and Ramucirumab in Previously Treated HER2+ Gastroesophageal Cancer

NCT04499924

Conditions
Adenocarcinoma Of Esophagus, Esophageal Adenocarcinoma, Gastric Adenocarcinoma, +1 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • Arizona Cancer Center / University of Arizona Tucson, Arizona, United States
  • City of Hope National Medical Center Duarte, California, United States
View all 48 locations
View Trial Details
Completed

The Microenvironment in Barrett's Esophagus

NCT03060642

Conditions
Adenocarcinoma Of Esophagus, Barrett Esophagus, Digestive System Diseases, +5 more
Locations
  • Mayo Clinic Rochester, Minnesota, United States
  • Columbia University Medical Center New York, United States
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
View Trial Details
Completed

Multiorgan Metabolic Imaging Response Assessment of Abemaciclib

NCT03339843

Conditions
Adenocarcinoma, Adenocarcinoma Of Esophagus, Carcinoma, +32 more
Locations
  • Universitair Ziekenhuis Antwerp, Belgium
  • Institut Jules Bordet Brussels, Belgium
  • Algemeen Ziekenhuis Groeninge Kortrijk, Belgium
  • CHC Saint-Joseph Liège, Belgium
View Trial Details
Completed

Trial of mFOLFOX6 + Trastuzumab + Avelumab in Gastric and Esophageal Adenocarcinomas

NCT03783936

Conditions
Adenocarcinoma Of Esophagus, Esophageal Adenocarcinoma, Gastric Adenocarcinoma, +7 more
Locations
  • City of Hope Duarte, California, United States
  • Winship Cancer Insititute of Emory University Atlanta, Georgia, United States
  • Northwestern University Feinberg School of Medicine Chicago, Illinois, United States
  • University of Iowa Hospital and Clinics Iowa City, Iowa, United States
View Trial Details
Completed

Evaluate Esophageal Reinforcement With ACell MatriStem Surgical Matrix: A Degradable Biologic Scaffold Material

NCT01970306

Conditions
Adenocarcinoma Of Esophagus, Esophageal Adenocarcinoma
Locations
  • Memorial Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering West Harrison Harrison, New York, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Md Anderson Cancer Center Houston, Texas, United States
View Trial Details
Completed

Efficacy of EsoGuard on Samples Collected Using EsoCheck Versus EGD for the Diagnosis of BE

NCT04293458

Conditions
Adenocarcinoma Of Esophagus, Barrett Esophagus, Barrett's Esophagus Without Dysplasia, +7 more
Locations
  • Lucid Investigative Site Orange, California, United States
  • Lucid Investigative Site Englewood, Colorado, United States
  • Lucid Investigative Site Naples, Florida, United States
  • Lucid Investigative Site Palm Harbor, Florida, United States
View all 27 locations
View Trial Details
Completed

PDR001 Plus LAG525 for Patients With Advanced Solid and Hematologic Malignancies

NCT03365791

Conditions
Adenocarcinoma Of Esophagus, Advanced Well-differentiated Neuroendocrine Tumors, Bronchial Neoplasms, +28 more
Locations
  • California Pacific Medical Center Drug Shipment (2) San Francisco, California, United States
  • Hematology Oncology Associates of the Treasure Coast Port Saint Lucie, Florida, United States
  • University Cancer and Blood Center, LLC Athens, Georgia, United States
  • Northwestern University Medical School Chicago, Illinois, United States
View all 20 locations
View Trial Details

Related conditions